Pfizer (PFE) reported Q3 2026 results on 3 Nov 2026. Earnings per share came in at $0.87, against an analyst average of $0.74, a surprise of +18.3%.
Revenue: $16.6B vs $15.9B expected. The quarter ended on 30 Sep 2026.
The company is valued at about $174.8B.
Figures from Yahoo Finance at the time of writing. Not investment advice.